ERBB2 and cancer: In this subset, pHer-2/neu expressing cancers were again found to have higher median (range) serum ECD values of 108.4 (6.1–510.0) ng ml−1, as compared to patients without pHer-2/neu expression (35.9, 5.2–6076.2 ng ml−1).